Novavax announced that NVX-CoV2373 COVID-19 vaccine has been recommended for Extended Conditional Marketing Authorization (CMA) in the European Union (EU) for adolescents 12-17 years of age.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its opinion on the results of the PREVENT-19 Pha...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
